these results suggest that the observed differences in lymphokine-activated killer cell activity can not be attributed to the level of interleukin 2 alone , and that response to this lymphokine is different among crohn 's disease , ulcerative colitis , and control intestine .
C0010346
crohn 's disease
C0021853
intestine